HBVZ10, an AAV8 vector-based new HBV therapy candidate for cccDNA elimination is a research paper published in Molecular Therapy — Methods & Clinical Development (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
US Office of Congressionally Directed Medical Research Programs
Grant: W81XWH-21-1-0065
French National Research Agency
Grant: ANR-17-RHUS-0003
National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Grant: 75N93020C00045
National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases
Grant: 75N930220C00042
European Commission
Grant: EU H2020-847939-IP-cure-B
NIAID NIH HHS
Grant: R37 AI043453
European Commission
Grant: 847939
Immune profiling to guide host-directed interventions to cure HBV infections
Small Business Innovation Research
National Institutes of Health
National Institute of Allergy and Infectious Diseases
U.S. Department of Defense
FWCI
0.69
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords